Ike Davis gets “last-ditch effort” cortisone injection as ankle surgery looms

2 Comments

The latest news on Ike Davis’ ankle injury isn’t good.

He got a cortisone shot yesterday and is slated to undergo an MRI exam over the weekend, with season-ending surgery looming if he doesn’t show significant improvement.

Davis has already been out for more than two months with an injury that was initially deemed minor and here’s the update he gave to Conor Orr of the Newark Star Ledger:

I wouldn’t say pessimistic, but I would say in three weeks, by the rule of the injury, if I’m not taking steps to play in three weeks, there’s something structurally wrong. If I could avoid surgery–surgery is not fun and sometimes stuff doesn’t feel the same after. And I’m trying to do as much as I can, the cortisone shot is like a last-ditch effort to see if we can push forward without having the surgery.

What makes the multiple setbacks Davis has experienced all the more frustrating is that he was off to a great start, following up an impressive rookie season by hitting .302 with seven homers and a .925 OPS through 36 games. Daniel Murphy and Lucas Duda haven’t been able to come close to that production and in his lengthy absence the Mets have slipped to the middle of the pack in overall OPS at first base for the season.

Report: Momentum in talks between Mariners, Jon Jay

Jon Durr/Getty Images
5 Comments

MLB.com’s Mark Feinsand reports that there is some momentum in talks between the Mariners and free agent outfielder Jon Jay.

Jay, 32, hit .296/.374/.375 in 433 plate appearances with the Cubs last season, which is adequate. He’s heralded more for his defense and his ability to play all three outfield spots.

The Mariners are losing center fielder Jarrod Dyson to free agency and likely don’t want to rely on Guillermo Heredia next season, hence the interest in Jay. The free agent class for center fielders is otherwise relatively weak.